Marino Scherillo Selected Research

Marino Scherillo Research Topics

Disease

9	Hemorrhage 09/2022 - 07/2012
6	Heart Failure 04/2024 - 12/2002
6	Acute Coronary Syndrome 09/2022 - 05/2007
4	Neoplasms (Cancer) 04/2024 - 09/2016
4	Stroke (Strokes) 01/2021 - 04/2013
3	Overweight 05/2017 - 09/2013
3	Hypertrophy 05/2003 - 01/2002
2	Myocardial Infarction 01/2021 - 12/2012
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 07/2012
2	Coronary Artery Disease (Coronary Atherosclerosis) 05/2017 - 06/2016
2	Pulmonary Embolism 05/2017 - 09/2016
2	Hypercholesterolemia 05/2017 - 06/2016
2	Renal Insufficiency (Renal Failure) 05/2017 - 09/2016
2	Atherosclerotic Plaque (Atheroma) 05/2017 - 06/2016
2	Atrial Fibrillation 06/2013 - 04/2013
1	Cardiotoxicity 04/2024
1	Cardiomyopathies (Cardiomyopathy) 04/2024
1	Sarcopenia 04/2024
1	Hematoma 09/2022
1	COVID-19 01/2020
1	Unstable Angina 08/2017
1	ST Elevation Myocardial Infarction 08/2017
1	Chronic Renal Insufficiency 08/2017
1	Non-ST Elevated Myocardial Infarction 08/2017
1	Sudden Infant Death (SID) 05/2017
1	Obesity 09/2013
1	Ischemic Stroke 06/2013
1	Myocardial Ischemia (Ischemic Heart Diseases) 04/2013
1	Thromboembolism 04/2013
1	Respiratory Sounds (Crackle) 12/2012
1	Left Ventricular Dysfunction 12/2012
1	Gynecomastia 12/2012
1	Thrombosis (Thrombus) 07/2012
1	Ventricular Tachycardia 04/2009
1	Syncope (Fainting) 04/2009
1	Cardiac Arrhythmias (Arrythmia) 04/2009
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2006
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 11/2004
1	Pathologic Constriction (Stenosis) 03/2003
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 02/2003

Drug/Important Bio-Agent (IBA)

7	AnticoagulantsIBA 12/2020 - 03/2013
3	CreatinineIBA 05/2017 - 03/2013
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 06/2016 - 07/2012
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 09/2013
2	CholesterolIBA 05/2017 - 06/2016
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 05/2006 - 12/2002
1	Guanylate Cyclase (Guanylyl Cyclase)IBA 04/2024
1	CytokinesIBA 04/2024
1	ChemokinesIBA 04/2024
1	AnthracyclinesIBA 04/2024
1	vericiguatIBA 04/2024
1	cangrelorIBA 09/2022
1	omega-Chloroacetophenone (Mace)IBA 01/2021
1	oxidized low density lipoproteinIBA 01/2020
1	PCSK9 InhibitorsIBA 01/2020
1	Ezetimibe (Zetia)FDA Link 01/2020
1	LDL CholesterolIBA 01/2020
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 11/2018
1	Neprilysin (Neutral Endopeptidase)IBA 10/2018
1	sacubitril and valsartan sodium hydrate drug combinationIBA 10/2018
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 10/2018
1	Enalapril FDA LinkGeneric 10/2018
1	Vitamin K FDA Link 05/2017
1	Clopidogrel (Plavix)FDA Link 06/2016
1	Heparin (Liquaemin)FDA LinkGeneric 06/2016
1	Cardiovascular AgentsIBA 09/2013
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 04/2013
1	Warfarin (Coumadin)FDA LinkGeneric 04/2013
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 03/2013
1	Spironolactone (Aldactone)FDA LinkGeneric 12/2012
1	Progesterone Receptors (Progesterone Receptor)IBA 12/2012
1	Eplerenone (Inspra)FDA LinkGeneric 12/2012
1	GlucocorticoidsIBA 12/2012
1	Mineralocorticoid Receptor AntagonistsIBA 12/2012
1	AndrogensIBA 12/2012
1	Glycoproteins (Glycoprotein)IBA 07/2012
1	Tirofiban (Aggrastat)FDA Link 07/2012
1	Eptifibatide (Integrilin)FDA Link 07/2012
1	Adenosine Triphosphate (ATP)IBA 04/2009
1	Valsartan (Vals)FDA Link 05/2006
1	anti-scl-70 autoantibodiesIBA 11/2004
1	Dipyridamole (Persantine)FDA LinkGeneric 03/2003

Therapy/Procedure

11	Therapeutics 12/2020 - 05/2006
2	Percutaneous Coronary Intervention 09/2022 - 01/2020
2	Myocardial Revascularization 05/2017 - 06/2016
2	Resistance Training 05/2003 - 01/2002
1	Punctures 09/2022
1	Patient Readmission 01/2019
1	Contraindications 11/2018
1	Stents 07/2012
1	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 04/2009
1	Critical Care (Surgical Intensive Care) 05/2007
1	Cardiac Resynchronization Therapy 01/2006
1	Endurance Training 02/2003